Olema Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-27. The offering totals $6.1M, of which $6.1M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| Marina Bozilenko | Director | Hayward, CA |
| Lawrence Fritz | Director | BRISBANE, CA |
| Peter Kusher | Director | San Francisco, CA |
| Andrei Manoliu | Director | San Francisco, CA |
| Peter Kusher | Executive Officer | San Francisco, CA |
| Gorjan Hrustanovic | Director | San Diego, CA |
| David C Myles, Ph.D. | Executive Officer | San Francisco, CA |
| Sandra L Horning, M.D. | Director | San Francisco, CA |
| Scott L Garland | Director | San Francisco, CA |
| Sean Bohen, M.D., Ph.D. | Director | San Francisco, CA |
| Sean Bohen, M.D., Ph.D. | Executive Officer | San Francisco, CA |
| Andrew C Rappaport | Director | San Francisco, CA |
| Graham L Walmsley, M.D., Ph.D. | Director | San Francisco, CA |
| Naseem C Zojwalla, M.D. | Executive Officer | San Francisco, CA |
| Yi C Larson | Director | San Francisco, CA |
| Cyrus L Harmon, Ph.D. | Director | San Francisco, CA |
| Shane C Kovacs | Executive Officer | San Francisco, CA |
| Ian L Clark | Director | San Francisco, CA |
| Gorjan L Hrustanovic, Ph.D. | Director | San Francisco, CA |
| Cynthia C Butitta | Director | San Francisco, CA |
| Frank McCormick | Director | PALO ALTO, CA |
| Frank McCormick | Executive Officer | PALO ALTO, CA |
| Ian Clark | Director | SOUTH SAN FRANCISCO, CA |
| David Myles | Executive Officer | Salt Lake City, UT |
| Cynthia Butitta | Director | Princeton, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-12-12 | D | $250.0M | $250.0M |
| 2023-09-14 | D | $130.0M | $130.0M |
| 2020-10-13 | D | $87.4M | $87.4M |
| 2020-06-23 | D/A | $55.4M | $53.9M |
| 2020-03-27 | D | $45.0M | $30.0M |